Steven J. Lobritto, MD

Board Certifications: 
Pediatric Transplant Hepatology, Pediatric Gastroenterology
Accepting New Patients
Treats Children
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Hepatitis, Endoscopy, Pediatric Inflammatory Bowel Disease (IBD), Pediatric Short Bowel Syndrome, Biliary Disease, Endoscopic Feeding Tube Placement, Small Bowel Problem, Intestinal Surgery, Liver Disease In Children, Pediatric Gastrointestinal (GI) Endoscopy, Liver Transplantation, Living Donor Transplantation, Abdominal Organ Transplantation, Liver Transplant, Pediatric

Academic Appointments

  • Associate Professor of Pediatrics at CUMC
  • Associate Professor of Medicine at CUMC

Administrative Titles

  • Medical Director, Pediatric Liver Transplantation, NewYork-Presbyterian/Columbia

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-3000

Location(s)

CUMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
Primary
White Plains, NY - 15 North Broadway Office
15 North Broadway
White Plains, NY 10601

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • MVP Health Care-Hudson Health Plan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

TRICARE

  • TRICARE

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO
  • The Empire Plan (NYSHIP)

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • New York Medical College, NY
  • MD, 1988 New York Medical College
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Pediatric Transplant Hepatology
  • Pediatric Gastroenterology

Honors & Awards

  • Alpha Omega Alpha Medical Honor Society
America's Top Doctor
NY Top Doctor

Research

Research Interests

  • Hepatitis B and C treatment in children
  • Non-alcoholic related fatty liver disease
  • Novel immunosuppression approaches in pediatric liver transplantation
  • Treatment and management of intestinal failure induced liver injury

Grants

AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR IN PEDIATRIC SUBJECTS WITH GENOTYPES 1AND 6 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION (P&S Industry Clinical Trial)

Jun 6 2017 - Jun 6 2022

DE NOVO AUTOIMMUNE HEPATITIS IN PEDIATRIC LIVER TRANSPLANT (Private)

Aug 1 2016 - Jul 31 2018

A TWO-PART, OPEN-LABEL, SINGEL-ARM PHASE 1/2 STUDY OF SAFETY, PHARMACOKINETICS AND EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN IN PEDIATRIC SUBJECTS AGED 3 TO 17 INFECTED WITH GENOTYPE 1 HEPATITIS C VIRUS (P&S Industry Clinical Trial)

Nov 5 2012 - Nov 5 2017

IMMUNOSUPRESSION WITHDRAWL FOR STABLE PEDIATRIC LIVER T (Federal Gov)

Jul 27 2012 - Jun 30 2017

A RANDOMIZED MULTICENTER, PHASE III STUDY EVALUATING THE EFF ICACY AND SAFETY OF PEGINTERFERON ALFA-2 (Private)

Oct 1 2011 - Mar 15 2013

AN OBSERVATIONAL STUDY OF THE CLINICAL CHARACTERISTICS AND DISEASE PROGRESSION OF PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY/CHOLESTERYL ESTER STORAGE DISEASE PHENOTYPE (Private)

Dec 20 2011 - Dec 19 2012

IMMUNOSUPPRESSION WITHDRAWAL FOR STABLE PEDIATRIC LIVER TRAN SPLANT RECIPIENTS (Federal Gov)

Sep 1 2011 - Mar 31 2012

A MULTI-CENTER GROUP TO STUDY ACCUTE LIVER FAILURE IN CHILDR EN (Federal Gov)

Sep 1 2009 - Aug 31 2010

A MULTI-CENTER TRIAL OF STUDY ACUTE LIVER FAILURE--DATA AND SPECIMEN COLLECTION (Federal Gov)

Sep 1 2005 - Aug 31 2010

PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV PED S C (Federal Gov)

Sep 1 2003 - Aug 31 2010

STUDIES OF PEDIATRIC LIVER TRANSPLANTATION(SPLIT) A MILTI- CENTER, PROSPECTIVE STUDY TO COLLECT DATA (Federal Gov)

Jun 1 2004 - Mar 31 2008

A MULTI-CENTER TRIAL TO STUDY ACUTE LIVER FAILURE (Federal Gov)

Sep 1 2002 - Aug 31 2005

Selected Publications

  • Salame E, Goldstein MJ, Kinkhabwala M, Kapur S, Finn R, Lobritto S, Brown R Jr., Emond JC: Model for end stage liver disease and Child-Turcotte-Pugh scores as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl. 2002, March 8(3):278-84
  • Nasr SH, Lobritto SJ, Lauring BP, Arend LJ< D’agati VD, Markowitz,GS: A rare complicationof monoclonalgammopathy. AM J Kidney Dis. 2002 Oct. 40(4):867-71.
  • Robert S. Brown, Jr., K. Shiva Kumar, Mark W. Russo, Milan Kinkhabwala, Diane L. Rudow, Patricia Harren, Steven J. Lobritto, Jean C. Emond: Model for End Stage Liver Disease and Child-Turcotte-Pugh Score as Predictors of Pretransplantation Disease Severity, Postransplantation Outcome, and Resource Utilization in United Network for Organ Sharing Status 2A Patients. Liver Transplantation, Vol 8, No3 (March), 2002: pp 278-284